We compared virus infectivity in macrophages and DC, and found that the virus origin determined the cell tropism of progeny virus. The highest efficiency of re-infection was seen for macrophage-derived dengue virus. Furthermore, in the presence of enhancing antibodies, macrophage-derived virus gave greater enhancement of infection compared with immature DCderived virus. Taken together, our results highlight the importance of macrophages in dengue infection.
In humans, DENV replicates predominantly in cells of the innate immune system, including immature dendritic cells (iDC), monocytes, macrophages (MF) and mature dendritic cells (mDC) (Boonnak et al., 2008; Jessie et al., 2004; Kangwanpong et al., 1995; Marovich et al., 2001; Miller et al., 2008; Pham et al., 2012; Sun et al., 2009; Wu et al., 2000) . iDC were found to be highly susceptible to DENV in the absence of antibodies. Multiple studies have shown that iDC do not support ADE (Boonnak et al., 2008 (Boonnak et al., , 2011 Marovich et al., 2001; Richter et al., 2014) . However, this appears to depend on the virus origin as iDC-derived DENV was described to facilitate ADE in iDC (Dejnirattisai et al., 2011) . Monocytes, MF and mDC are less susceptible to DENV than are iDC in the absence of antibodies, but facilitate ADE (Blackley et al., 2007; Boonnak et al., 2011; Halstead et al., 1980) . Thus, the literature suggests that distinct subsets of cells are important for DENV viraemia in the absence and in the presence of enhancing concentrations of DENV-specific antibodies.
Although there is much evidence that the above-mentioned cell types are important during DENV infection, no studies have reported a systematic paired analysis on the infectious properties of DENV in primary MF, iDC and mDC and determined how susceptibility relates to the production of progeny virions in these cells. Hence, that was the aim of this study. Furthermore, we assessed if and how the origin of the virus influences its tropism, both in both the absence and presence of DENV antibodies.
Following a mosquito bite, DENV is deposited into the skin and bloodstream (Styer et al., 2007) , where it will encounter potential target cells. Therefore, we first investigated the susceptibility of MF, iDC and mDC to DENV2 derived from the mosquito cell line C6/36 (Ayala-Nunez et al., 2011) . Human monocytes were isolated from buffy coats (Sanquin Bloodbank, Netherlands) and differentiated into MF and iDC, as previously described (Miller et al., 2008; Richter et al., 2014) . Maturation of iDC into mDC was performed according to a published protocol (Boonnak et al., 2008) . Fig. S1 (available in the online Supplementary Material) shows the surface marker expression pattern of the resulting cells and confirms the expected phenotype.
Primary human iDC, mDC and MF were infected with DENV2 strain 16681 at a m.o.i. of 1 and 10, unless indicated otherwise. DENV infectivity was assessed on the basis of the percentage of infected cells (flow cytometric analysis using the 3H5 antibody) and the number of DENV2 produced in the supernatant in terms of genome-equivalent copies [GEc; as determined by quantitative reverse-transcription PCR (qRT-PCR); (van der Schaar et al., 2007) ], and infectious particles (p.f.u. assay; van der Schaar et al., 2007) . Virus infectivity was determined at 24 h post-infection (p.i.) Fig. 1 (a) shows a representative dot blot of the percentage of infected MF, iDC and mDC. In line with previous publications (Boonnak et al., 2011; Marovich et al., 2001; Wu et al., 2000) , we observed that iDCs are highly susceptible to DENV infection. The fraction of infected iDC did not increase between m.o.i. 1 and 10, while the number of infected MF and mDC further increased between m.o.i. 1 and 10 (Fig. 1a) . In agreement with these results, m.o.i.-dependent virus particle production was seen up to at least m.o.i. 10 for MF (Fig. S2 ). For iDC, m.o.i.-dependent growth was only observed below m.o.i. 1 (Fig. S2) .
Next, we evaluated the number of GEc and p.f.u. secreted from infected cells (Fig. 1b, c) . The data are summarized in Table S1 , which shows that, at m.o.i. 10, iDC produced 10-fold more GEc than did MF, yet comparable numbers of infectious particles were detected (Table S1 , based on paired samples from cells of the same donor). At m.o.i. 1, iDC produced close to 100-fold more GEc than did MF and mDC. Interestingly, comparable numbers of infectious virus particles were secreted by iDC and mDC. MF produced 10-fold lower numbers of infectious particles than did iDC and mDC. The discord between the GEc and p.f.u. titres of iDC suggests that these cells produce low-infectious virus particles. Indeed, the GEc/p.f.u. ratio calculated for individual donors revealed that the infectivity of iDC-derived DENV was lower (~3500) compared with that of MFderived DENV (~400) after infection at m.o.i. 10. At m.o.i. 1, the GEc/p.f.u. ratio was approximately 1700 for iDCderived DENV and 250 for MF-derived DENV. DENV particles secreted from mDC had the highest infectivity (~25 ,  Table S1 ). Boonnak et al. (2011) also determined the number of physical and infectious particles from infected iDC, MF and mDC, yet did not report the infectivity (GEc/p.f.u.). For comparison, we calculated the GEc/p.f.u. ratio based on the information in their report, and found a ratio of~100 for MF,~1 for iDC and below 1 for mDC. A GEc/p.f.u. ratio below 1 is not possible, so caution is required as we cannot deduce whether the data points are derived from paired samples. However, it is clear that our ratios are different from those extracted from the report of Boonnak et al. (2011) . These authors used Vero cells for initial virus production and plaque titration whilst we used C6/36 cells and BHK-21 clone 15 cells, respectively. To rule out that the cell type used for plaque titration was responsible for the differences in the results, we attempted to perform DENV plaque assays on Vero cells. However, the three Vero cell lineages (Vero-ATCC, Vero-WHO and Vero-E6) available in our lab did not support DENV plaque formation. As an alternative approach, we applied flow cytometry to assess the infectivity of the viruses on Vero cells. Fig. S2 (f) clearly shows that MF-derived DENV is more infectious than iDCderived DENV in Vero-WHO cells, which is in line with the infectivity observed in BHK-21-clone 15 cells. Furthermore, when comparing the infectivity of DENV2 produced by C6/ 36 cells and by Vero-WHO cells, the infectivity did not differ between these two producer cell lines (Fig. S2g) . Hence, our observation that iDC-derived DENV has a lower infectivity than MF-derived DENV2 is not influenced by the cell lines used to produce virus stocks or to quantify infectious titres.
Collectively, we conclude that during the first round of infection with mosquito-derived virus, iDC are the most susceptible cell type. iDC produce more particles compared with DENV-infected MF and mDC but these iDC-derived particles exhibit relatively low-grade infectivity.
An earlier report showed that iDC-derived DENV cannot infect new iDC (Dejnirattisai et al., 2011) . This finding prompted us to further investigate the role of virus origin in cell tropism of progeny DENV2. To this end, we tested the capacity of iDC-and MF-derived DENV2 to infect MF and iDC. The technical limitations of culturing a large batch of mDCs prevented us from producing sufficient mDCderived DENV2 stocks and subsequent testing of this virus origin. We decided to infect MF and iDC on the basis of an (Dejnirattisai et al., 2011) , we found that iDC are least susceptible towards iDC-derived virions, followed by MF-and C6/36-derived DENV (Fig. 2a) . MF, however, were equally susceptible to iDC-and MF-derived DENV albeit the infectivity was very low (~0.5 % at m.o. g. 500). Again, MF were infected more readily by mosquito-derived DENV2 than by mammalian cell-derived DENV2 in MF (Fig. 2a ).
The differences in infectivity for MF-and iDC-derived virions might be caused by soluble factors, e.g. cytokines, present in the supernatants of infected cells. Given the known antiviral properties of IFNa (Diamond et al., 2000) , we first determined the IFNa concentration by ELISA (IBL International) . Surprisingly, MF supernatants contained higher concentrations of IFNa than did iDC supernatants: in two donors we found 475.3 pg ml À1 versus 24.1 pg ml
À1
, and 166.9 pg ml À1 versus 20.8 pg ml
, respectively. Thus, the lower infectivity of iDC-derived DENV2 cannot be explained by IFNa. We next tested whether other soluble factors present within DENV-infected cell supernatants are important for infectivity. To this end, cell supernatants were first subjected to UV treatment to impair the infectious properties of DENV present within the supernatant.
Indeed, no viral plaques were observed in the UV-inactivated cell supernatants. Then, a fixed number of C6/36-derived DENV GEc was incubated with several dilutions of UV-treated cell supernatants for 1 h at 37 C and viral infectivity was measured by plaque assay. Fig. 2(b) shows that both iDC and MF supernatants possess antiviral properties (<100 % of expected C6/36-titres), yet no differences were seen between the two supernatant origins. This indicates that the differences in infectivity of progeny virions derived from MF and iDC cannot be explained by the concentration of IFNa or other soluble factors in the medium. Another possibility is that iDC secrete a large number of defective interfering particles. Indeed, defective interfering particles are seen in dengue patients (Li et al., 2011) . Secretion of defective interfering particles is often related to the m.o.i. used to infect cells: the higher the m.o.i. the lower the infectivity (Fuller & Marcus, 1980; Lyles & Rupprecht, 2007) . In line with this, we observed that the infectivity of DENV was lower when the virus had been produced in cells infected with a high m.o.i. (Figs 1d and S3b) .
We thus far showed that the origin of the virus determines its tropism in the absence of antibodies, but we did not know whether the origin of the virus also influences infection under conditions of ADE. We focused on MF and mDC, as these experiments have already been performed for iDC (Dejnirattisai et al., 2011) . First, we determined the infectivity of mosquito cell-derived DENV2 in MF and mDC after incubating the virus with serial dilutions of human DENV-immune sera. The sera were obtained from Nicaraguan patients with an acute secondary DENV infection (Narvaez et al., 2011 ; kind gift Dr Eva Harris, University of California, Berkeley). At 26 h p.i., the fraction of infected cells was determined by flow cytometry (Fig. 3a) . MF showed peak enhancement of infection at high concentrations of serum antibodies, whereas mDC demonstrated peak enhancement at very low concentrations (Fig. 3a) . Similar results were obtained when sera was used from two other DENV-infected patients (data not shown). These results suggest that serum antibodies co-determine the host cell tropism of DENV2 and point towards a MF-oriented tropism under conditions with high DENV antibody titres. Contrary to infection of MF, infection of mDC and iDC will be suppressed under conditions of high levels of serum antibodies ( Fig. 3a ; Boonnak et al., 2011; Richter et al., 2014 ).
Next, we tested whether the ADE-effect observed was dependent on the origin of the virus. Given the large number of conditions involved, we were not able to perform paired analyses in primary cells from the same donor. Therefore, we decided to use murine MF-like P338D1 cells for these experiments. P338D1 cells express Fcg receptors I-III (Ochiai et al., 1988; Sung, 1985) , and can be infected with DENV2 in the absence and the presence of antibodies (Ayala-Nunez et al., 2013; Huang et al., 2006) . To avoid possible epitope-and isotype-biased results, two murine antibodies targeting two different epitopes were used: a flavivirus-reactive antibody against the envelope protein fusion loop (4G2, IgG2a; Fig. 3b ) and a DENV2-specific antibody against the envelope protein domain III (3H5, IgG1; Fig. S3a ). P338D1 cells were infected with iDCderived, MF-derived and C6/36-derived DENV2 at m.o.g. 500 in the presence of a range of antibody concentrations (Figs 3b and S3a). Virus production was scored at 48 h p.i. by plaque assay. Comparable baseline titres and ADE profiles were obtained for MF-derived, iDC-derived and C6/ 36-derived DENV2 in P338D1 cells. Yet, the highest fold enhancement of infection was seen for MF-derived DENV2 virions. This effect was independent of the epitope (Fig. 3b vs Fig. S3a) .
We conclude that mosquito-derived DENV particles are prone to infect iDC (Fig. 1) . Subsequently, infected iDC produce progeny DENV2. However, this iDC-derived DENVproduction is hallmarked by a low ratio of infectious virus to total virus production ( Fig. 1d and Table S1 ). Hence, there is low efficacious re-infection of other iDC and MF ( Fig. 2a ; Dejnirattisai et al., 2011) . MF-derived DENV is more infectious in iDC than in MF (Fig. 2a) . The lower susceptibility of MF and mDC is compensated for by the higher infectivity of progeny virus. Therefore, we postulate that DC and MF contribute equally to DENV dissemination.
The observation that iDC produce virions with lowinfectious properties is intriguing. It is not known why iDC produce large numbers of low-quality virions, yet it is tempting to speculate that this serves to facilitate efficient priming of the adaptive immune system as described for other viruses (Freigang et al., 2005; Honke et al., 2011) . Future research is required to address this observation in more detail.
Our results imply that during secondary infection, when anti-DENV antibodies are present, the cell tropism of DENV changes. Early in infection, the serum antibody concentration is low and therefore mosquito-derived virus likely infects primarily iDC through interaction with the virus receptor. During subsequent rounds of infection, both iDC (Dejnirattisai et al., 2011) and MF (Fig. 3b) contribute to viraemia and support ADE of DENV infection. The relative importance of iDC and MF in DENV ADE warrants further study. In MF, the highest fold enhancement of DENV production is seen for virions derived from MF (Fig. 3b) , which suggests that macrophages play an important role in virus dissemination during secondary infection.
